Clinical trial
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Osteoarthritis
NCT07641517 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Osteoarthritis
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- June 25, 2026
- Completion date
- April 30, 2027
- Enrollment
- 150 (estimated)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.